EQS-News: Biotech Company Pleased With Results Of Early Test

EQS-News: Pasithea Therapeutics Corp. Biotech Company Pleased With Results Of Early Testing Demonstrating Vaccine Potential For Multiple Sclerosis 03.10.2022 / 15:09 CET/CEST The issuer is solely responsible for the content of this announcement. Learn More about Pasithea Therapeutics by gaining ...

Related Keywords

United States , Camille Baptiste , Epstein Barr , Tiago Reis Marques , Hooke Laboratories Inc , Nasdaq , Distribution Services , Biotech Company Pleased With , Astrazeneca , National Ms Society , Moderna Inc , Pasithea Therapeutics Corporation , News Service , National Academy Of Sciences Professor Lawrence Steinman , Pasithea Therapeutics Corp , Pasithea Therapeutics , National Academy , Sciences Professor Lawrence Steinman , Mimic Epstein Barr , Hooke Laboratories , Therapeutics Corporation , Amyotrophic Lateral Sclerosis , Multiple Sclerosis , Corporate News , Regulatory Announcements , Results , F , Early , Testing , Emonstrating , Vaccine , Potential , Or , Multiple , Clerosis , Et Cest , The , More , Asithea , Herapeutics ,